Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002082730-25-000001·CS DIAGNOSTICS CORP.
Schedule 13G ownership disclosure
CS DIAGNOSTICS CORP.
Common Stock (CUSIP 33852L202) and Series B Preferred Stock (no CUSIP assigned) · CUSIP: 33852L202
Event date: 2025-09-30
- Filing-level shares
- 13,392,434.00
- Percent of class
- 9.9%
- Graus Thomas
Shares: 13,392,434.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002082730-25-000001
- Form type
- SCHEDULE 13G
- Filer
- CS DIAGNOSTICS CORP.
- CIK
- CIK 1106861
- Filed
- Oct 06, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership